Engineers Gate Manager LP Curis Inc Transaction History

Engineers Gate Manager LP

  • $4.27 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$0.47 - $17.22 $19 - $723
-42 Reduced 0.27%
15,611 $8,000
Q3 2022

Nov 14, 2022
SELL
$0.74 - $15.01 $20,803 - $421,976
-28,113 Reduced 64.23%
15,653 $11,000
Q2 2022

Aug 15, 2022
BUY
$0.71 - $2.43 $21,620 - $73,995
30,451 Added 228.7%
43,766 $43,000
Q1 2022

May 16, 2022
BUY
$2.31 - $5.13 $30,757 - $68,305
13,315 New
13,315 $32,000

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email